Ann Med Surg
10.1016/j.tibtech.2011.01.008 59 WangZ.Colombi CiacchiL.WeiG
Also, even with a modest amount of weight loss, which we can achieve without even going to a GLP-1, that weight management model can reduce your body weight enough to prevent developing type 2 diabetes over the next 10-20 years
Reported outcomes in investigational incretin-based therapies often include changes in body weight, waist circumference, glycemic indices (e.g., HbA1c in populations with diabetes or prediabetes), blood pressure, lipids, and liver-related biomarkers
Evidence may include medical records, testimonies, and documentation
Furthermore, total somatostatin output was reduced by DT treatment (total response 973 143 fmol/75 min vs 1820 359 in control mice